Features

The Web browser has evolved into a platform for our digital lives, offering more interactivity while moving further beyond its passive browsing roots (i.e., checking e-mail, paying bills and balancing checkbooks, watching videos, social networking, playing games, networking and even managing a law practice). That is precisely the core of Google's new Web browser called Chrome.

Features

Progressive corporations are starting to treat e-discovery as any other standard corporate business process: repeatable, defensible and measurable. This new dynamic raises an obvious question: What portions of the e-discovery process are best suited to be "in-sourced," and how do IT professionals within an enterprise work with their partners to ensure effective collaboration/communication?

Who's doing what; who's going where.

Features

Recent litigation of interest to you and your practice.

Features

The different ' sometimes even higher ' product standards required by non-American countries can adversely affect product protection here in the United States, as plaintiff's attorneys can use these discrepancies to their advantage in litigation against product manufacturers.

Features

Although the issue of Federal Preemption has grabbed the headlines in medical device and pharmaceutical cases, those analyzing preemption's impact on plaintiff's failure-to-warn claims on other types of products that are subject to federal regulation are significant for their varied results.

Statutory consumer-protection laws are rapidly displacing common law tort principles. Those behind this disturbing trend say that these lawsuits (typically class actions) represent a "different avenue of relief for a different type of injury." Most admit, however, that they are actually running consumer class actions for "risk of injury" because personal-injury class action torts are too difficult to certify.

Features

In recent years, pharmaceutical and medical device manufacturers have faced an increased number of creative product liability claims arising from alleged actions of their sales representatives. Medical device manufacturers may face a challenge in preventing these claims because of the unique role of these representatives.